Lechner K - Search Results

1

1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.

Muhm M, Grois N, Kier P, Stümpflen A, Kyrle P, Pabinger I, Bettelheim P, Hinterberger W, Lechner K. Muhm M, et al. Among authors: lechner k. Haemostasis. 1990;20(1):15-20. doi: 10.1159/000216100. Haemostasis. 1990. PMID: 2108912

2

Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?

Eichinger S, Pabinger I, Kyrle PA, Köller U, Kier P, Schneider B, Lechner K. Eichinger S, et al. Among authors: lechner k. Haemostasis. 1992;22(1):25-31. doi: 10.1159/000216288. Haemostasis. 1992. PMID: 1521824

3

Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.

Eichinger S, Pabinger I, Hartl H, Stain C, Mayerhofer S, Schweiger C, Kier P, Schwarzinger I, Kyrle PA, Lechner K. Eichinger S, et al. Among authors: lechner k. Thromb Haemost. 1990 Aug 13;64(1):108-12. Thromb Haemost. 1990. PMID: 1980381

4

Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays.

Pabinger I, Kyrle PA, Speiser W, Stoffels U, Jung M, Lechner K. Pabinger I, et al. Among authors: lechner k. Thromb Haemost. 1990 Jun 28;63(3):407-12. Thromb Haemost. 1990. PMID: 2402742

5

Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).

Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I. Knöbl P, et al. Among authors: lechner k. Thromb Haemost. 1995 Oct;74(4):1035-8. Thromb Haemost. 1995. PMID: 8560408

6

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.

Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA. Eichinger S, et al. Among authors: lechner k. Thromb Haemost. 1997 Apr;77(4):624-8. Thromb Haemost. 1997. PMID: 9134632 Clinical Trial.

7

Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis.

Schwarzinger I, Stain-Kos M, Bettelheim P, Pabinger I, Kyrle P, Kalhs P, Kapiotis S, Jäger U, Lechner K. Schwarzinger I, et al. Among authors: lechner k. Thromb Haemost. 1992 Dec 7;68(6):648-51. Thromb Haemost. 1992. PMID: 1287879

8

Rituximab for the treatment of acquired antibodies to factor VIII.

Sperr WR, Lechner K, Pabinger I. Sperr WR, et al. Among authors: lechner k. Haematologica. 2007 Jan;92(1):66-71. doi: 10.3324/haematol.10553. Haematologica. 2007. PMID: 17229637 Free article. Review.

9

Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.

Pabinger I, Brücker S, Kyrle PA, Schneider B, Korninger HC, Niessner H, Lechner K. Pabinger I, et al. Among authors: lechner k. Blood Coagul Fibrinolysis. 1992 Oct;3(5):547-53. Blood Coagul Fibrinolysis. 1992. PMID: 1450321

10

Anticardiolipin antibodies in patients with venous thrombosis.

Kapiotis S, Speiser W, Pabinger-Fasching I, Kyrle PA, Lechner K. Kapiotis S, et al. Among authors: lechner k. Haemostasis. 1991;21(1):19-24. doi: 10.1159/000216197. Haemostasis. 1991. PMID: 1907589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters